BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29497840)

  • 21. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy.
    Morsy H; Maher R; Negm D
    J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Alopecia areata during ustekinumab administration: Co-existence or an adverse reaction?
    Verros C; Rallis E; Crowe M
    Dermatol Online J; 2012 Jul; 18(7):14. PubMed ID: 22863636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
    Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
    Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata.
    Tavakolpour S
    Scand J Immunol; 2016 May; 83(5):345-6. PubMed ID: 26939767
    [No Abstract]   [Full Text] [Related]  

  • 25. Alopecia areata.
    Hon KL; Leung AK
    Recent Pat Inflamm Allergy Drug Discov; 2011 May; 5(2):98-107. PubMed ID: 21453266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.
    Renert-Yuval Y; Guttman-Yassky E
    Adv Ther; 2017 Jul; 34(7):1594-1609. PubMed ID: 28646393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of alopecia areata: on the cusp and in the future.
    Price VH
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):207-11. PubMed ID: 14582675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new biologics in psoriasis: possible treatments for alopecia areata.
    McMichael AJ
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):217-8. PubMed ID: 14582677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy.
    Barahmani N; Lopez A; Babu D; Hernandez M; Donley SE; Duvic M
    Clin Exp Dermatol; 2010 Jun; 35(4):409-16. PubMed ID: 19874320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
    Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
    Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of emerging immunotherapies in psoriasis.
    Yiu ZZ; Warren RB
    Immunotherapy; 2015; 7(2):119-33. PubMed ID: 25713988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified immunotherapy for alopecia areata.
    Yoshimasu T; Furukawa F
    Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.
    AbuHilal M; Walsh S; Shear N
    J Cutan Med Surg; 2016 Nov; 20(6):509-516. PubMed ID: 27207350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice.
    Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Kissling S; Hummel S; Vitacolonna M; Kopp-Schneider A; Zöller M
    J Invest Dermatol; 2005 Nov; 125(5):945-51. PubMed ID: 16297194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turner's syndrome associated with psoriasis and alopecia areata.
    Rosina P; Segalla G; Magnanini M; Chieregato C; Barba A
    J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):50-2. PubMed ID: 12602969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum concentrations of IL-2, IL-6, IL-12 and TNF-α in patients with alopecia areata.
    Rossi A; Cantisani C; Carlesimo M; Scarnò M; Scali E; Mari E; Garelli V; Maxia C; Calvieri S
    Int J Immunopathol Pharmacol; 2012; 25(3):781-8. PubMed ID: 23058031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alopecia areata: autoimmunity--the evidence is compelling.
    Kalish RS; Gilhar A
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association analysis of IL1A and IL1B variants in alopecia areata.
    Tazi-Ahnini R; McDonagh AJ; Cox A; Messenger AG; Britton JE; Ward SJ; Båvik CO; Duff GW; Cork MJ
    Heredity (Edinb); 2001 Aug; 87(Pt 2):215-9. PubMed ID: 11703512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alopecia areata following adalimumab.
    Kirshen C; Kanigsberg N
    J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward the Clonotype Analysis of Alopecia Areata-Specific, Intralesional Human CD8+ T Lymphocytes.
    Bertolini M; Uchida Y; Paus R
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):9-12. PubMed ID: 26551936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.